Overview
- Danish registry data on roughly two million citizens highlighted Bacteroides fragilis bloodstream infections in patients, some of whom were diagnosed with colorectal cancer shortly afterward, prompting targeted microbial analyses.
- Researchers identified previously undescribed bacteriophages residing in Bacteroides fragilis that appeared more frequently in individuals with colorectal cancer.
- In 877 stool samples from Europe, the United States, and Asia, colorectal cancer patients were about twice as likely to carry the viral sequences as those without cancer.
- Exploratory analyses indicated that selected viral traces identified about 40% of colorectal cancer cases in tested samples, suggesting preliminary stool-based screening potential that requires further validation.
- The study, published in Communications Medicine in February 2026, emphasizes association rather than causation, with follow-up experiments in artificial gut systems, tumor tissue, and mouse models now underway.